Scimagix Raises $25M in Private Financing Round | GenomeWeb

NEW YORK, July 20 – Informatics software provider Scimagix said this week that it had raised $25 million in a third found of private financing.

Dresdner Kleinwort Capital and EuclidSR Partners led the financing round. Tullis-Dickerson, Invesco, Future Capital, and IngleWood Ventures also participated in the financing round. Daniel Green, a director at Dresdner Kleinwort Capital, and Barbara Dalton, a partner at EuclidSR Partners, will take seats on the company’s board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.